The trademark application MetaboMIR Therapeutics was filed by Philippe CAMUS, a national of the French Republic (the "Applicant") and Marc THIBONNIER, a national of the United States of America (the "Co-Applicant", and jointly with the "Applicant" referred to as the "Applicants" going forward). The application was published for oppositions on October 22, 2020, and it was registered by office on January 29, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).